Biostatistician

View Bill’s LinkedIn Profile

Bill has focused on early stage companies with novel devices in new markets. Prior to Inari Medical, Bill served as CEO of Visualase, Inc., which developed and sold lasers for minimally invasive neurosurgery. The company was acquired by Medtronic for $105M in July, 2014, having raised less than $10m in equity funding. Prior to Visualase, Bill was Vice President of Sales at FoxHollow, Inc., helping to build a commercial team and revenue ramp that led to a successful IPO in 2004 and an acquisition by EV3 in 2007. Bill’s first early stage med tech experience was as head of sales at RITA Medical Systems, an interventional oncology company that enjoyed a successful IPO in 2000. He spent the early part of his career in various sales roles at Ethicon and Medtronic.

View Tara’s LinkedIn Profile

Tara has extensive multi-functional medical device experience across a range of start-ups and larger organizations. Her most recent role was as the Venous Business Segment Leader at Volcano Corporation, acquired by Philips in 2015. Tara’s venous business experienced explosive triple digit growth in her time at the helm. Prior to Philips Volcano, she worked at Medtronic in Corporate Development where she participated in numerous transactions including the ~$816M acquisition of Kanghui Holdings in China and the divestiture of its Physio-Control business unit to Bain Capital for $487M. Tara also worked as a project leader at a healthcare strategy consulting firm called Health Advances and as Manager, Clinical and Regulatory Affairs at InfraReDx. She earned an A.B. in Biology from Harvard University, a M.S. in Regulatory Affairs and Health Policy from the Massachusetts College of Pharmacy and a M.B.A from Harvard Business School. Tara was a member of the National Championship winning ice hockey team and Ivy league championship team in softball while at Harvard. She also went on to compete in the National Women’s Hockey League (NWHL) for two seasons.

View John’s LinkedIn Profile

John brings over 25 years of extensive commercial experience with early stage and mature medical device companies. His most recent roles were VP of Global Sales and Marketing at Trireme Medical and Area VP of Sales at Medtronic/Covidien Venous Vascular.  Prior to that he was VP of Sales and Marketing at Cardiovascular Systems Inc. (CSI), where he created/executed the commercial strategy driving revenue growth from $5M to $43M in year 1 of commercial launch.  Prior to CSI, John was the US Director of Sales at Fox Hollow Technologies where he played an integral role in the aggressive revenue ramp in their early commercial years.  Other successful start up’s that he was a part of prior to Fox Hollow: Novoste Corporation, Arterial Vascular Engineering and Heartport Inc. John earned his Bachelor of Science in Business Marketing from the University of Massachusetts at Lowell where he played Division 1 college hockey for four years.

View Andrew’s LinkedIn Profile

Drew is a proven medical device operating executive with broad functional, geographic and sector experience.  From 2012-2016 Drew served as the VP of Commercial Operations at Sequent Medical where he led the commercialization strategy for the WEB Aneurysm Embolization system from early prototype to broad adoption in the European market.  Sequent was acquired by Terumo Corporation in July 2016 for $380 million.  Prior to Sequent, Drew spent 11 years at Medtronic.  His roles at Medtronic included the VP of Marketing for the AF Solutions business, VP of Clinical and Regulatory for the AF Solutions business and Director of Investor Relations.  Drew also spent three years on an expatriate assignment in Europe leading the launch of Medtronic’s first drug eluting coronary stent.  Prior to Medtronic, he spent four years at ABN AMRO bank in Chicago focused on healthcare transactions.  He earned a B.B.A. in Finance from the University of Wisconsin and an MBA from Harvard Business School.

View Eric’s LinkedIn Profile